SCHEMBL6188658

SCHEMBL6188658

CC(O)C(Oc1ccccc1)SC(c1ccc(Cl)cc1)c1ccc(Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 3/20 0.40
SLC6A2 P23975 2/20 0.40
SLC6A3 Q01959 2/20 0.40
IDO1 P14902 2/20 0.38
TDO2 P48775 2/20 0.38
PPARG P37231 4/20 0.38
PPARA Q07869 4/20 0.38
POLB P06746 2/20 0.37
MAPK1 P28482 2/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CNR2 P34972 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6185867 0.87 CNR2 (0.43) POLBMAPK1MEN1KMT2ACNR2
SCHEMBL6186229 0.80 ADRB2 (0.38) SLC6A4SLC6A3IDO1TDO2POLB
SCHEMBL6186361 0.77 PPARG (0.43) SLC6A4SLC6A2SLC6A3PPARGPPARA
SCHEMBL6187841 0.75 CYP2D6 (0.43) SLC6A4SLC6A2SLC6A3IDO1TDO2
SCHEMBL6186208 0.73 PPARG (0.43) SLC6A4PPARGPPARALMNAMEN1
SCHEMBL6192279 0.70 BRD4 (0.45) SLC6A4SLC6A3PPARGPPARAPOLB
SCHEMBL6187976 0.69 ADRB2 (0.41) SLC6A4SLC6A3IDO1TDO2POLB
SCHEMBL5289693 0.68 PPARG (0.49) SLC6A4SLC6A2SLC6A3PPARGPPARA
SCHEMBL10977277 0.67 SLC6A4 (0.52) SLC6A4SLC6A3IDO1TDO2MAPK1
SCHEMBL15617669 0.67 SLC6A2 (0.49) SLC6A4SLC6A2SLC6A3IDO1TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1539685-A1 MCP-1 RECEPTOR ANTAGONISTS AND METHOD OF USE THEREOF Warner-Lambert Company LLC (US) 2005-06-15 EP disclosed
WO-2004014847-A1 MCP-1 RECEPTOR ANTAGONISTS AND METHOD OF USE THEREOF WARNER-LAMBERT COMPANY LLC (US) 2004-02-19 WO disclosed